VistaGen Therapeutics Stock (VTGN)
Track VistaGen Therapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, Action Alerts PLUS portfolio activity, contributor watchlist signals, and Pro price levels.
VTGN
VistaGen Therapeutics
healthcare
$0.64
▼ -1.81 (-74.49%) past year
Market Cap
$25.23M
P/E Ratio
—
1Y Return
-74.49%
EPS (TTM)
-$1.58
Read the latest TheStreet Pro articles mentioning VistaGen Therapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning VTGN yet.
Daily Diary Mentions
0 mentionsNo diary mentions for VTGN yet.